- Home
- NISN vs ACHL Comparison
NISN vs ACHL Comparison
Compare NISN & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- ACHL
- Stock Information
- Founded
- NISN 2005
- ACHL 2016
- Country
- NISN China
- ACHL United Kingdom
- Employees
- NISN N/A
- ACHL N/A
- Industry
- NISN Metal Fabrications
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NISN Industrials
- ACHL Health Care
- Exchange
- NISN Nasdaq
- ACHL Nasdaq
- Market Cap
- NISN 46.0M
- ACHL 46.8M
- IPO Year
- NISN 2016
- ACHL 2021
- Fundamental
- Price
- NISN $5.60
- ACHL $1.14
- Analyst Decision
- NISN
- ACHL Buy
- Analyst Count
- NISN 0
- ACHL 2
- Target Price
- NISN N/A
- ACHL $4.00
- AVG Volume (30 Days)
- NISN 98.5K
- ACHL 266.7K
- Earning Date
- NISN 10-15-2024
- ACHL 11-14-2024
- Dividend Yield
- NISN N/A
- ACHL N/A
- EPS Growth
- NISN 12.54
- ACHL N/A
- EPS
- NISN 4.19
- ACHL N/A
- Revenue
- NISN $452,263,984.00
- ACHL N/A
- Revenue This Year
- NISN N/A
- ACHL N/A
- Revenue Next Year
- NISN N/A
- ACHL N/A
- P/E Ratio
- NISN $1.34
- ACHL N/A
- Revenue Growth
- NISN 86.06
- ACHL N/A
- 52 Week Low
- NISN $3.14
- ACHL $0.63
- 52 Week High
- NISN $22.55
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- NISN 41.11
- ACHL 55.79
- Support Level
- NISN $5.16
- ACHL $1.12
- Resistance Level
- NISN $6.34
- ACHL $1.18
- Average True Range (ATR)
- NISN 0.74
- ACHL 0.05
- MACD
- NISN 0.05
- ACHL -0.00
- Stochastic Oscillator
- NISN 17.60
- ACHL 33.33
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.